Catalyst Event
Johnson & Johnson (JNJ) · Other
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
3/18/2026, 12:00:00 AM
Importance is Medium as FDA approval of a first-in-class drug typically has a significant impact on valuation. The U.S. FDA approved ICOTYDE™ (icotrokinra) on March 18, 2026, which analysts forecast to be a major growth driver, forecasted
Korean Translation
신약 승인은 기업 가치에 유의미한 영향을 미치므로 중요도를 Medium으로 산정함. 2026년 3월 18일, 미국 FDA가 ICOTYDE™(icotrokinra)를 승인하였으며, 이는 분석가들에 의해 주요 성장 동력이 될 것으로 예상됨.
Related Recent Events
CrowdStrike Holdings Inc (CRWD) · Earnings Release
Next earnings release for Q1 2027 is scheduled for 2026-06-09, with analysts forecasting an EPS of $1.07 estimated.
6/9/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision (PDUFA date) for LEQEMBI IQLIK (lecanemab) subcutaneous autoinjector for treatment initiation in Alzheimer's disease on 2026-05-24; high importance is estimated as FDA approval for a major drug formulation typically results in ≥10% price impact, scheduled.
5/24/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Walmart's earnings release for Q1 FY2027 is scheduled. A medium impact is estimated as earnings releases are key volatility drivers for retail stocks, expected.
5/21/2026, 12:00:00 AM
ONEOK Inc (OKE) · Other
ONEOK 2026 Annual Meeting of Shareholders on May 20, 2026, scheduled.
5/20/2026, 12:00:00 AM
Fair Isaac Corporation (FICO) · Other
FICO World 2026 is scheduled to take place from May 19-22, 2026.
5/19/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Other
Google I/O 2026 developer conference is scheduled for 2026-05-19. Developer conferences usually have a 1-5% price impact. Updates on AI, Gemini, and Android are expected.
5/19/2026, 12:00:00 AM